Interestingly, hepatic SIRT3 was also reported to be reduced in mouse models of NAFLD and in NASH patients compared with control subjects (23, 31) suggesting a significant role for SIRT3 in NAFLD. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.